リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory department」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory department

Watanabe, Keisuke Asai, Yoshihito Tsurikisawa, Naomi Oshikata, Chiyako Kaneko, Takeshi 名古屋大学

2020.08

概要

Streptococcus pneumoniae is the most common pathogen for community-acquired pneumonia and is also common in nursing and healthcare-associated pneumonia. Pneumococcal vaccine shows clinical benefit and 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been introduced in a routine immunization program in Japan. However, uptake of PPSV23 remains low, at 40%. One opportunity for capturing unvaccinated subjects is hospital referrals. Identifying factors associated with pneumococcal vaccination among referred subjects is thus important so that pulmonologists can maximize the capture of unvaccinated subjects. We retrospectively reviewed the records of subjects with a first referral to the Department of Respiratory Medicine at Hiratsuka City Hospital from September 2017 to March 2018. Subjects who were ≥65 years old and lived in Hiratsuka were included in this study. We compared the backgrounds of subjects and investigated factors associated with pneumococcal vaccination. A total of 142 individuals were included in this study and the pneumococcal vaccination rate was 44.4% (95% confidence interval (CI), 36.0–52.9%). Of these, 127 subjects regularly visited clinics and/or hospitals for any diseases and their pneumococcal vaccine rate was 44.1% (95%CI, 35.3–53.2%). In multivariate analysis, chronic respiratory diseases (odds ratio 5.7; 95%CI, 2.2–14.9, P<0.001) and receipt of PPSV23 notification (odds ratio 8.5; 95%CI, 2.5–29.0, P<0.001) were positively associated with pneumococcal vaccination. In conclusion, chronic respiratory diseases and receipt of PPSV23 notification were positively associated with pneumococcal vaccination. However, pneumococcal vaccination rates remain relatively low, even in subjects regularly visiting clinics and/or hospitals.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Eurich DT, Marrie TJ, Minhas-Sandhu JK, et al. Ten-year mortality after community-acquired pneumonia: a

prospective cohort. Am J Respir Crit Care Med. 2015;192(5):597–604. doi: 10.1164/rccm.201501-0140OC.

2. Shah FA, Pike F, Alvarez K, et al. Bidirectional relationship between cognitive function and pneumonia.

Am J Respir Crit Care Med. 2013;188(5):586–592. doi: 10.1164/rccm.201212-2154OC.

3. Kato T, Miyashita N, Kawai Y, et al. Changes in physical function after hospitalization in patients with

nursing and healthcare-associated pneumonia. J Infect Chemother. 2016;22(10):662–666. doi: 10.1016/j.

jiac.2016.06.005.

4. Kurai D, Sasaki Y, Saraya T, et al. Pathogen profiles and molecular epidemiology of respiratory viruses in

Japanese inpatients with community-acquired pneumonia. Respir Investig. 2016;54(4):255–263. doi: 10.1016/j.

resinv.2016.01.001.

5. Noguchi S, Mukae H, Kawanami T, et al. Bacteriological assessment of healthcare-associated pneumonia

using a clone library analysis. PLoS One. 2015;10(4):e0124697. doi: 10.1371/journal.pone.0124697.

6. Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect.

2014;20(Suppl 5):45–51. doi: 10.1111/1469-0691.12461.

7. Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin

Infect Dis. 2008;47(10):1328–1338. doi: 10.1086/592691.

8. Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Effectiveness of the 23-valent pneumococcal

polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years:

3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014;58(7):909–917. doi: 10.1093/cid/ciu002.

9. Suzuki M, Dhoubhadel BG, Ishifuji T, et al. Serotype-specific effectiveness of 23-valent pneumococcal

polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre,

prospective, test-negative design study. Lancet Infect Dis. 2017;17(3):313–321. doi: 10.1016/S14733099(17)30049-X.

10. Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced

death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.

Clin Infect Dis. 2006;42(8):1093–1101. doi: 10.1086/501354.

11. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal

pneumonia in adults. N Engl J Med. 2015;372(12):1114–1125. doi: 10.1056/NEJMoa1408544.

12. Naito T, Yokokawa H, Watanabe A. Impact of the national routine vaccination program on 23-valent

pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother.

2018;24(6):496–498. doi: 10.1016/j.jiac.2018.01.004.

13. Di Nardo F, Calabrò GE, Ianuale C, et al. Capturing the chance for pneumococcal vaccination in the

hospital setting. Ann Ist Super Sanita. 2017;53(4):291–298. doi: 10.4415/ANN_17_04_04.

14. Christenson B, Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza

and pneumococcal infection. Epidemiol Infect. 2002;129(3):515–524. doi: 10.1017/s095026880200780x.

15. Higuchi M, Narumoto K, Goto T, et al. Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study. BMC Fam

Pract. 2018;19(1):153. doi: 10.1186/s12875-018-0841-3.

16. Shono A, Hoshi SL, Kondo M. The impact on vaccination coverage following introduction of a routine

pneumococcal vaccination programme for the elderly in Japan. Vaccine. 2018;36(39):5886–5890. doi:

10.1016/j.vaccine.2018.08.023.

17. Murakami Y, Kanazu S, Petigara T, et al. Factors associated with PPSV23 coverage among older adults

in Japan: a nationwide community-based survey. BMJ Open. 2019;9(7):e030197. doi: 10.1136/bmjopen-2019-030197.

18. Hua C, Morel J, Ardouin E, et al. Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2015;54(4):748–750. doi: 10.1093/rheumatology/keu531.

19. Loubet P, Verger P, Abitbol V, et al. Pneumococcal and influenza vaccine uptake in adults with inflammatory

bowel disease in France: results from a web-based study. Dig Liver Dis. 2018;50(6):563–567. doi: 10.1016/j.

dld.2017.12.027.

20. Kanda Y. Investigation of the freely-available easy-to-use software “EZR” (Easy R) for medical statistics.

476

Keisuke Watanabe et al

Bone Marrow Transplant. 2013;48(3):452–458. doi: 10.1038/bmt.2012.244.

21. Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in

Europe: a literature review. Thorax. 2013;68(11):1057–1065. doi: 10.1136/thoraxjnl-2013-204282.

22. Klett-Tammen CJ, Krause G, Seefeld L, et al. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP).

BMC Public Health. 2016;16:121. doi: 10.1186/s12889-016-2784-8.

23. Loubet P, Kernéis S, Groh M, et al. Attitude, knowledge and factors associated with influenza and

pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine.

2015;33(31):3703–3708. doi: 10.1016/j.vaccine.2015.06.012.

24. Sakamoto A, Chanyasanha C, Sujirarat D, et al. Factors associated with pneumococcal vaccination in elderly

people: a cross-sectional study among elderly club members in Miyakonojo City, Japan. BMC Public Health.

2018;18:1172. doi: 10.1186/s12889-018-6080-7.

25. Naito T, Matsuda N, Tanei M, Watanabe Y, Watanabe A. Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the

free vaccination campaign after the Great East Japan Earthquake. J Infect Chemother. 2014;20(7):450–453.

doi: 10.1016/j.jiac.2014.03.004.

26. Jiménez-García R, Hernandez-Barrera V, Rodríguez-Rieiro C, et al. Comparison of self-report influenza

vaccination coverage with data from a population based computerized vaccination registry and factors

associated with discordance. Vaccine. 2014;32(35):4386–4392. doi: 10.1016/j.vaccine.2014.06.074.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る